BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8953609)

  • 1. NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network.
    Baker LH; Hanks G; Gershenson D; Kantoff P; Lange P; Logothetis C; Sandler H; Walsh P
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):265-88. PubMed ID: 8953609
    [No Abstract]   [Full Text] [Related]  

  • 2. NCCN Practice Guidelines for Prostate Cancer.
    Bahnson RR; Hanks GE; Huben RP; Kantoff P; Kozlowski JM; Kuettel M; Lange PH; Logothetis C; Pow-Sang JM; Roach M; Sandler H; Scardino PT; Taylor RJ; Urban DA; Walsh PC; Wilson TG;
    Oncology (Williston Park); 2000 Nov; 14(11A):111-9. PubMed ID: 11195405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of the NCCN guidelines for treatment of prostate cancer.
    Millikan R; Logothetis C
    Oncology (Williston Park); 1997 Nov; 11(11A):180-93. PubMed ID: 9430189
    [No Abstract]   [Full Text] [Related]  

  • 4. NCCN and ACS collaborate on a patient's version of the NCCN practice guidelines for breast cancer. National Comprehensive Cancer Network. American Cancer Society.
    Rose VL
    Am Fam Physician; 1999 Nov; 60(7):2169-70. PubMed ID: 10569514
    [No Abstract]   [Full Text] [Related]  

  • 5. The NCCN/American Cancer Society partnership.
    McGivney WT; McGinnis L; Gansler TS;
    Oncology (Williston Park); 2000 Nov; 14(11A):213-6. PubMed ID: 11195412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer.
    J Natl Compr Canc Netw; 2011 May; 9(5):xxxvii-xlii. PubMed ID: 21739727
    [No Abstract]   [Full Text] [Related]  

  • 7. NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network.
    Carlson RW; Goldstein LJ; Gradishar WJ; Lichter AS; McCormick B; Moe RE; Theriault RL
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):47-75. PubMed ID: 8953596
    [No Abstract]   [Full Text] [Related]  

  • 8. [NCCN Asian consensus statement - can Asian patients with cancer accept treatment modalities from NCCN guidelines ?].
    Ozono S; Hinotsu S; Namiki M; Akaza H
    Gan To Kagaku Ryoho; 2014 Jun; 41(6):683-6. PubMed ID: 25129079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCCN Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.
    Demetri G; Elias A; Gershenson D; Fossella F; Grecula J; Mittal B; Raschko J; Robertson J
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):179-94. PubMed ID: 8953602
    [No Abstract]   [Full Text] [Related]  

  • 10. The NCCN guideline program--1998.
    Winn RJ; Botnick WZ; Brown NH
    Oncology (Williston Park); 1998 Nov; 12(11A):30-4. PubMed ID: 10028501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCCN Ovarian Cancer Practice Guidelines. The National Comprehensive Cancer Network.
    Morgan RJ; Copeland L; Gershenson D; Locker G; McIntosh D; Ozols R; Teng N
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):293-310. PubMed ID: 8953610
    [No Abstract]   [Full Text] [Related]  

  • 12. Financial modeling for global pricing: the NCCN breast cancer prototype. National Comprehensive Cancer Network.
    Perkel SJ
    Oncology (Williston Park); 1999 May; 13(5A):73-4. PubMed ID: 10370923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCCN practice guidelines for upper gastrointestinal carcinomas. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):179-223. PubMed ID: 10028512
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate cancer early detection clinical practice guidelines in oncology.
    Babaian RJ; Partin AW;
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S42-55. PubMed ID: 19795575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate cancer: interpretation of management guidelines].
    Ploussard G; Desgrandchamps F
    Rev Prat; 2013 Apr; 63(4):515-20. PubMed ID: 23682482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between urologists in the United States and Canada in the approach to prostate cancer.
    Fleshner N; Rakovitch E; Klotz L
    J Urol; 2000 May; 163(5):1461-6. PubMed ID: 10751858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCCN practice guidelines for occult primary tumors. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):226-309. PubMed ID: 10028513
    [No Abstract]   [Full Text] [Related]  

  • 18. NCCN Acute Leukemia Practice Guidelines. The National Comprehensive Cancer Network.
    O'Donnell MR; Appelbaum F; Bishop M; Estey EH; Grever M; Maslak P
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):205-21. PubMed ID: 8953604
    [No Abstract]   [Full Text] [Related]  

  • 19. Variations in the use of prostate cancer staging tests: results from one NCCN Institution.
    Bennett CL; Yang T; Nadler R
    Oncology (Williston Park); 1997 Nov; 11(11A):155-7. PubMed ID: 9430186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACP issues guidelines on the early detection of prostate cancer and screening for prostate cancer.
    Rose VL
    Am Fam Physician; 1997 Oct; 56(6):1674-5. PubMed ID: 9351433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.